Categories AlphaGraphs, Earnings, Health Care
Key highlights from Johnson & Johnson’s (JNJ) Q2 2025 earnings results
Johnson & Johnson (NYSE: JNJ) reported its second quarter 2025 earnings results today.
Reported sales increased 5.8% year-over-year to $23.7 billion. Operational sales growth was 4.6%.
Net earnings grew over 18% to $5.5 billion, or $2.29 per share, compared to last year. Adjusted EPS dropped 1.8% to $2.77.
Revenue and earnings beat expectations.
The company saw sales in the US increase 7.8% to $13.5 billion while international sales grew 3.2% to $10.2 billion.
Sales in the Innovative Medicine segment rose 4.9% to $15.2 billion while sales in the MedTech segment increased 7.3% to $8.5 billion.
For full-year 2025, JNJ expects reported sales to range between $93.2-93.6 billion while adjusted EPS is expected to be $10.80-10.90.
The stock gained 2% in premarket hours on Wednesday.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Lamb Weston (LW) Q2 2026 Earnings: Key financials and quarterly highlights
Lamb Weston Holdings, Inc. (NYSE: LW) reported its second quarter 2026 earnings results today. Net sales inched up 1% year-over-year to $1.62 billion. Net sales at constant currency remained flat.
Paychex reports higher Q2 FY26 revenue and earnings; EPS beats estimates
Paychex Inc. (NASDAQ: PAYX) on Friday reported stronger-than-expected adjusted earnings for the second quarter of fiscal 2026. Revenues grew 18% year-over-year. The Rochester-based human capital management solutions provider reported revenues
Key highlights from NIKE’s (NKE) Q2 2026 earnings results
NIKE, Inc. (NYSE: NKE) reported revenues of $12.4 billion for the second quarter of 2026, which were up 1% on a reported basis and flat on a currency-neutral basis compared
